These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Teratogen update: methotrexate. Hyoun SC; Običan SG; Scialli AR Birth Defects Res A Clin Mol Teratol; 2012 Apr; 94(4):187-207. PubMed ID: 22434686 [TBL] [Abstract][Full Text] [Related]
5. Fetal methotrexate and misoprostol exposure: the past revisited. Wheeler M; O'Meara P; Stanford M Teratology; 2002 Aug; 66(2):73-6. PubMed ID: 12210010 [TBL] [Abstract][Full Text] [Related]
6. Recognition in adult patients of malformations induced by folic-acid antagonists. Reich EW; Cox RP; Becker MH; Genieser NB; McCarthy JG; Converse JM Birth Defects Orig Artic Ser; 1978; 14(6B):139-60. PubMed ID: 728558 [TBL] [Abstract][Full Text] [Related]
7. Importance of timing of gestational exposure to methotrexate for its teratogenic effects when used in setting of misdiagnosis of ectopic pregnancy. Poggi SH; Ghidini A Fertil Steril; 2011 Sep; 96(3):669-71. PubMed ID: 21733506 [TBL] [Abstract][Full Text] [Related]
8. Congenital cardiac defects: a possible association of aminopterin syndrome and in utero methotrexate exposure? Piggott KD; Sorbello A; Riddle E; DeCampli W Pediatr Cardiol; 2011 Apr; 32(4):518-20. PubMed ID: 21327892 [TBL] [Abstract][Full Text] [Related]
9. Teratogenicity studies with methotrexate, aminopterin, and acetylsalicylic acid in domestic cats. Khera KS Teratology; 1976 Aug; 14(1):21-7. PubMed ID: 960008 [TBL] [Abstract][Full Text] [Related]
11. Two siblings with fetal hydantoin syndrome. Ozkinay F; Yenigün A; Kantar M; Ozkinay C; Avanoğlu A; Ulman I Turk J Pediatr; 1998; 40(2):273-8. PubMed ID: 9677735 [TBL] [Abstract][Full Text] [Related]
12. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. Kozma C Am J Med Genet; 2001 Jan; 98(2):168-75. PubMed ID: 11223853 [TBL] [Abstract][Full Text] [Related]
14. Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Ornoy A Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988 [TBL] [Abstract][Full Text] [Related]
15. [Isotretinoin embryopathy. Report of one case]. Troncoso Sch M; Rojas H C; Bravo C E Rev Med Chil; 2008 Jun; 136(6):763-6. PubMed ID: 18769834 [TBL] [Abstract][Full Text] [Related]
16. Methotrexate embryopathy after exposure to low weekly doses in early pregnancy. Martín MC; Barbero P; Groisman B; Aguirre MÁ; Koren G Reprod Toxicol; 2014 Jan; 43():26-9. PubMed ID: 24513926 [TBL] [Abstract][Full Text] [Related]
17. Low dose weekly methotrexate in early pregnancy. A case series and review of the literature. Ostensen M; Hartmann H; Salvesen K J Rheumatol; 2000 Aug; 27(8):1872-5. PubMed ID: 10955326 [TBL] [Abstract][Full Text] [Related]
18. [Fetal hydantoin syndrome in siblings]. Schinzel A Schweiz Med Wochenschr; 1979 Jan; 109(3):68-72. PubMed ID: 104383 [TBL] [Abstract][Full Text] [Related]
19. Combined chemotherapy and teratogenicity. Paskulin GA; Gazzola Zen PR; de Camargo Pinto LL; Rosa R; Graziadio C Birth Defects Res A Clin Mol Teratol; 2005 Sep; 73(9):634-7. PubMed ID: 16104005 [TBL] [Abstract][Full Text] [Related]
20. Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype? Enns GM; Roeder E; Chan RT; Ali-Khan Catts Z; Cox VA; Golabi M Am J Med Genet; 1999 Sep; 86(3):237-41. PubMed ID: 10482872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]